RA'ANANA, Israel, April 1,
2024 /PRNewswire/ -- Inspira Technologies OXY B.H.N.
Ltd. (Nasdaq: IINN, IINNW) (the "Company" or "Inspira"), today
announced a strategic investment by leading investor, Mr.
Ronen Juster, and the mother of
Inspira's Chief Executive Officer, Ms. Margi Ben-Noon. The Company has entered into a
definitive agreement for the issuance and sale of an aggregate of
1,339,285 of ordinary shares at a price per share of $1.232, in a registered direct offering. The
offering is expected to close on or about April 2, 2024, subject to the satisfaction of
customary closing conditions.
The proceeds to Inspira from the offering are expected to be
$1.65 million Inspira currently
intends to use the net proceeds from the offering for working
capital and general corporate purposes.
The securities described above are being offered and sold by the
Company in a registered direct offering pursuant to a "shelf"
registration statement on Form F-3 (Registration No. 333-266748),
including a base prospectus, previously filed with the Securities
and Exchange Commission (SEC) on August 10,
2022, and declared effective by the SEC on August 18, 2022. The offering of such securities
is being made only by means of a prospectus supplement that forms a
part of the registration statement. A final prospectus supplement
and an accompanying base prospectus relating to the registered
direct offering will be filed with the SEC and will be available on
the SEC's website located at http://www.sec.gov.
This press release shall not constitute an offer to sell or a
solicitation of an offer to buy these securities, nor shall there
be any sale of these securities in any state or jurisdiction in
which such offer, solicitation or sale would be unlawful prior to
the registration or qualification under the securities laws of any
such state or jurisdiction.
Inspira Technologies OXY B.H.N. Ltd.
Inspira Technologies is leading the way in transforming
life-support care. Its innovative solutions are paving the way for
direct blood oxygenation, bypassing the lungs, and potentially
reducing the need for traditional mechanical ventilation. Beyond
this, the Company is committed to advancing blood circulation
technology and incorporating AI-driven monitoring systems. These
advancements are part of its strategy to offer more
patient-focused, data-informed care. The integration of these
technologies signifies the potential to enhance patient outcomes
and streamline hospital operations, marking a new era in
respiratory care.
For more information, please visit our corporate website:
https://inspira-technologies.com/
Forward-Looking Statement Disclaimer
This press release contains express or implied forward-looking
statements under U.S. Federal securities laws. These
forward-looking statements and their implications are based only on
the current expectations of the management of the Company. They are
subject to several factors and uncertainties that could cause
results to differ materially from those described in the
forward-looking statements, such as market and other conditions.
For example, the Company uses forward-looking statements when it
discusses the completion of the offering, the satisfaction of
customary closing conditions related to the offering and the
anticipated use of proceeds therefrom. Except as otherwise required
by law, the Company undertakes no obligation to publicly release
any revisions to these forward-looking statements to reflect events
or circumstances after the date hereof or the occurrence of
unanticipated events. More detailed information about the risks and
uncertainties affecting the Company is contained under the heading
"Risk Factors" in the Company's annual report on Form 20-F for the
fiscal year ended December 31, 2023,
filed with the SEC, which is available on the SEC's website,
http://www.sec.gov.
For more details:
Public Relations Manager
Adi Shmueli
Inspira Technologies
info@inspirao2.com
+972-9-9664485
Logo -
https://mma.prnewswire.com/media/1668495/Inspira_Technologies_Logo.jpg
View original
content:https://www.prnewswire.com/news-releases/inspira-announces-1-65-million-registered-direct-offering-of-ordinary-shares-by-inspira-ceos-mother-with-leading-fund-manager-302104437.html
SOURCE Inspira Technologies